186 related articles for article (PubMed ID: 23812637)
1. Epigenetic regulation of organic anion transporting polypeptide 1B3 in cancer cell lines.
Imai S; Kikuchi R; Tsuruya Y; Naoi S; Nishida S; Kusuhara H; Sugiyama Y
Pharm Res; 2013 Nov; 30(11):2880-90. PubMed ID: 23812637
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation profiles of organic anion transporting polypeptide 1B3 in cancer cell lines.
Ichihara S; Kikuchi R; Kusuhara H; Imai S; Maeda K; Sugiyama Y
Pharm Res; 2010 Mar; 27(3):510-6. PubMed ID: 20130966
[TBL] [Abstract][Full Text] [Related]
3. Cancer-type Organic Anion Transporting Polypeptide 1B3: Current Knowledge of the Gene Structure, Expression Profile, Functional Implications and Future Perspectives.
Furihata T; Sun Y; Chiba K
Curr Drug Metab; 2015; 16(6):474-85. PubMed ID: 26264344
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Liver- and Cancer-type-Organic Anion Transporting Polypeptide (OATP) 1B3 Messenger RNA Expression in Normal and Cancerous Human Tissues.
Alam K; Farasyn T; Ding K; Yue W
Drug Metab Lett; 2018; 12(1):24-32. PubMed ID: 29577869
[TBL] [Abstract][Full Text] [Related]
5. OATP1B3-1B7, a novel organic anion transporting polypeptide, is modulated by FXR ligands and transports bile acids.
Malagnino V; Hussner J; Issa A; Midzic A; Meyer Zu Schwabedissen HE
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G751-G762. PubMed ID: 31509437
[TBL] [Abstract][Full Text] [Related]
6. Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker.
Morio H; Sun Y; Harada M; Ide H; Shimozato O; Zhou X; Higashi K; Yuki R; Yamaguchi N; Hofbauer JP; Guttmann-Gruber C; Anzai N; Akita H; Chiba K; Furihata T
Biol Pharm Bull; 2018; 41(3):445-449. PubMed ID: 29491222
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.
Lee W; Belkhiri A; Lockhart AC; Merchant N; Glaeser H; Harris EI; Washington MK; Brunt EM; Zaika A; Kim RB; El-Rifai W
Cancer Res; 2008 Dec; 68(24):10315-23. PubMed ID: 19074900
[TBL] [Abstract][Full Text] [Related]
8. Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.
Svoboda M; Wlcek K; Taferner B; Hering S; Stieger B; Tong D; Zeillinger R; Thalhammer T; Jäger W
Biomed Pharmacother; 2011 Sep; 65(6):417-26. PubMed ID: 21719246
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal region of organic anion transporting polypeptide 1B3 (OATP1B3) plays an essential role in regulating its plasma membrane trafficking.
Chun SE; Thakkar N; Oh Y; Park JE; Han S; Ryoo G; Hahn H; Maeng SH; Lim YR; Han BW; Lee W
Biochem Pharmacol; 2017 May; 131():98-105. PubMed ID: 28216016
[TBL] [Abstract][Full Text] [Related]
10. Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells.
Nagai M; Furihata T; Matsumoto S; Ishii S; Motohashi S; Yoshino I; Ugajin M; Miyajima A; Matsumoto S; Chiba K
Biochem Biophys Res Commun; 2012 Feb; 418(4):818-23. PubMed ID: 22326869
[TBL] [Abstract][Full Text] [Related]
11. Amino acid residues in transmembrane domain 10 of organic anion transporting polypeptide 1B3 are critical for cholecystokinin octapeptide transport.
Gui C; Hagenbuch B
Biochemistry; 2008 Sep; 47(35):9090-7. PubMed ID: 18690707
[TBL] [Abstract][Full Text] [Related]
12. Organic anion transporting polypeptide 1B3 can form homo- and hetero-oligomers.
Zhang Y; Boxberger KH; Hagenbuch B
PLoS One; 2017; 12(6):e0180257. PubMed ID: 28644885
[TBL] [Abstract][Full Text] [Related]
13. The effect of breast cancer resistance protein, multidrug resistant protein 1, and organic anion-transporting polypeptide 1B3 on the antitumor efficacy of the lipophilic camptothecin 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in vitro.
Tsakalozou E; Adane ED; Kuo KL; Daily A; Moscow JA; Leggas M
Drug Metab Dispos; 2013 Jul; 41(7):1404-13. PubMed ID: 23620484
[TBL] [Abstract][Full Text] [Related]
14. Role of hypoxia inducible factor-1α in the regulation of the cancer-specific variant of organic anion transporting polypeptide 1B3 (OATP1B3), in colon and pancreatic cancer.
Han S; Kim K; Thakkar N; Kim D; Lee W
Biochem Pharmacol; 2013 Sep; 86(6):816-23. PubMed ID: 23924606
[TBL] [Abstract][Full Text] [Related]
15. Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma.
Asensio M; Herraez E; Macias RIR; Lozano E; Muñoz-Bellvís L; Sanchez-Vicente L; Morente-Carrasco A; Marin JJG; Briz O
Biochem Pharmacol; 2023 Aug; 214():115681. PubMed ID: 37429423
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.
Schwarz UI; Meyer zu Schwabedissen HE; Tirona RG; Suzuki A; Leake BF; Mokrab Y; Mizuguchi K; Ho RH; Kim RB
Pharmacogenet Genomics; 2011 Mar; 21(3):103-14. PubMed ID: 21278621
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.
Ishiguro N; Maeda K; Saito A; Kishimoto W; Matsushima S; Ebner T; Roth W; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2008 Apr; 36(4):796-805. PubMed ID: 18180273
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of organic anion transporting polypeptide 1B3 and copper transporter 1 expression in endometrial cancer patients treated with paclitaxel and carboplatin.
Ogane N; Yasuda M; Kameda Y; Yokose T; Kato H; Itoh A; Nishino S; Hashimoto Y; Kamoshida S
Biomed Res; 2013 Jun; 34(3):143-51. PubMed ID: 23782748
[TBL] [Abstract][Full Text] [Related]
19. [Advances in the study of organic anion transporting polypeptide 1B3].
Li X; Li Y
Yao Xue Xue Bao; 2011 Nov; 46(11):1279-85. PubMed ID: 22260016
[TBL] [Abstract][Full Text] [Related]
20. Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology.
Sun Y; Piñón Hofbauer J; Harada M; Wöss K; Koller U; Morio H; Stierschneider A; Kitamura K; Hashimoto M; Chiba K; Akita H; Anzai N; Reichelt J; Bauer JW; Guttmann-Gruber C; Furihata T
Cancer Lett; 2018 Oct; 433():107-116. PubMed ID: 29960051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
